Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Encapsulated Cell Technology-Based Delivery of a Complement Inhibitor Reduces Choroidal Neovascularization in a Mouse Model

Published:2018-03-09 Issue:2 Volume:7 Page:3
ISSN:2164-2591
Container-title:Translational Vision Science & Technology
language:en
Short-container-title:Trans. Vis. Sci. Tech.

Author:

Annamalai Balasubramaniam¹,Parsons Nathaniel¹,Belhaj Marwa²,Brandon Carlene¹,Potts Jay²,Rohrer Bärbel¹³⁴

Affiliation:

1. Departments of Ophthalmology, Medical University of South Carolina, Charleston, SC, USA

2. Department of Cell Biology, University of South Carolina, Columbia, SC, USA

3. Neurosciences, Division of Research, Medical University of South Carolina, Charleston, SC, USA

4. Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

Ophthalmology,Biomedical Engineering

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Encapsulated cell technology: Delivering cytokines to treat posterior ocular diseases;Pharmacological Research;2024-05

2. Regulatable Complement Inhibition of the Alternative Pathway Mitigates Wet Age-Related Macular Degeneration Pathology in a Mouse Model;Translational Vision Science & Technology;2023-07-18

3. Novel Drug Delivery Methods and Approaches for the Treatment of Retinal Diseases;Asia-Pacific Journal of Ophthalmology;2023-06-30

4. Contribution of animal models to the mechanistic understanding of Alternative Pathway and Amplification Loop (AP/AL)‐driven Complement‐mediated Diseases;Immunological Reviews;2022-10-06

5. Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine;Frontiers in Physiology;2022-02-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3